Although alpha-fetoprotein (AFP) is commonly applied as a tumor indicator for the diagnosis of HCC, its low specificity and accuracy are its shortage, which leads to patients missing the best treatment period (Liang Y. et al., 2021). Here, AFP is linked to hepatocellular carcinoma.